Evidence map›Paper›PMID 27403739›Full record

ArticlePLoS medicine2016

Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.

Matthew J O'Brien, Ji Young Lee, Mercedes R Carnethon, Ronald T Ackermann, Maria C Vargas, Andrew Hamilton, Nivedita Mohanty, Sarah S Rittner, Jessica N Park, Amro Hassan and 3 more

Abstract read
In one paragraph

Article in PLoS medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. PREVENT-DM Comparative Effectiveness Trial of Lifestyle Intervention and Metformin.American journal of preventive medicine · 2017 · on this map
    Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Increasing Diabetes Screening in a Primary Care Setting.Clinical diabetes : a publication of the American Diabetes Association · 2022
    Article
  9. Screening for Diabetes and Prediabetes.Endocrinology and metabolism clinics of North America · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Preventing Diabetes in Primary Care: Providers' Perspectives About Diagnosing and Treating Prediabetes.Clinical diabetes : a publication of the American Diabetes Association · 2018
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Matthew J O'BrienDivision of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
Ji Young LeeDivision of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.ORCID 0000-0002-6102-0510
Mercedes R CarnethonDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
Ronald T AckermannDivision of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
Maria C VargasDivision of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
Andrew HamiltonAlliance of Chicago Community Health Services, L3C, Chicago, Illinois, United States of America.
Nivedita MohantyAlliance of Chicago Community Health Services, L3C, Chicago, Illinois, United States of America.
Sarah S RittnerAlliance of Chicago Community Health Services, L3C, Chicago, Illinois, United States of America.
Jessica N ParkAlliance of Chicago Community Health Services, L3C, Chicago, Illinois, United States of America.
Amro HassanAlliance of Chicago Community Health Services, L3C, Chicago, Illinois, United States of America.
David R BuchananDivision of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.ORCID 0000-0002-5103-2219
Lei LiuDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.ORCID 0000-0003-1844-338X
Joseph FeinglassDivision of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.

Funding

Research Design, Data, and Analytics CoreP30DK092949 · NIDDK · UNIVERSITY OF CHICAGO · PI ELBERT S. HUANG · 2011 to 2026
$10.0M
Promotora-Led Intervention to Promote Weight Loss in Latinas at-risk for DiabetesK23DK095981 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI O'BRIEN, MATTHEW JAMES · 2012 to 2016
$890k
AHRQ HHS P01 HS021141NIDDK NIH HHS K23 DK095981NIDDK NIH HHS P30 DK092949
6 · The paper itself

Abstract

backgroundIn 2015, the United States Preventive Services Task Force (USPSTF) recommended targeted screening for prediabetes and diabetes (dysglycemia) in adults who are aged 40 to 70 y old and overweight or obese. Given increasing prevalence of dysglycemia at younger ages and lower body weight, particularly among racial/ethnic minorities, we sought to determine whether the current screening criteria may fail to identify some high-risk population subgroups. METHODS AND

findingsWe investigated the performance of the 2015 USPSTF screening recommendation in detecting dysglycemia among US community health center patients. A retrospective analysis of electronic health record (EHR) data from 50,515 adult primary care patients was conducted. Longitudinal EHR data were collected in six health centers in the Midwest and Southwest. Patients with a first office visit between 2008 and 2010 were identified and followed for up to 3 y through 2013. We excluded patients who had dysglycemia at baseline and those with fewer than two office visits during the follow-up period. The exposure of interest was eligibility for screening according to the 2015 USPSTF criteria. The primary outcome was development of dysglycemia during follow-up, determined by: (1) laboratory results (fasting/2-h postload/random glucose ≥ 100/140/200 mg/dL [5.55/7.77/11.10 mmol/L] or hemoglobin A1C ≥ 5.7% [39 mmol/mol]); (2) diagnosis codes for prediabetes or type 2 diabetes; or (3) antidiabetic medication order. At baseline, 18,846 (37.3%) participants were aged ≥40 y, 33,537 (66.4%) were overweight or obese, and 39,061 (77.3%) were racial/ethnic minorities (34.6% Black, 33.9% Hispanic/Latino, and 8.7% Other). Overall, 29,946 (59.3%) patients had a glycemic test within 3 y of follow-up, and 8,478 of them developed dysglycemia. Only 12,679 (25.1%) patients were eligible for screening according to the 2015 USPSTF criteria, which demonstrated the following sensitivity and specificity (95% CI): 45.0% (43.9%-46.1%) and 71.9% (71.3%-72.5%), respectively. Racial/ethnic minorities were significantly less likely to be eligible for screening yet had higher odds of developing dysglycemia than whites (odds ratio [95% CI]: Blacks 1.24 [1.09-1.40]; Hispanics 1.46 [1.30-1.64]; and Other 1.33 [1.16-1.54]). In addition, the screening criteria had lower sensitivity in all racial/ethnic minority groups compared to whites. Limitations of this study include the ascertainment of dysglycemia only among patients with available test results and findings that may not be generalizable at the population level.

conclusionsTargeted diabetes screening based on new USPSTF criteria may detect approximately half of adult community health center patients with undiagnosed dysglycemia and proportionately fewer racial/ethnic minorities than whites. Future research is needed to estimate the performance of these screening criteria in population-based samples.

Indexed as

AdultAgedCommunity Health CentersDiabetes Mellitus, Type 2FemaleHumansMaleMass ScreeningMiddle AgedPrediabetic StateRacial GroupsRetrospective StudiesRisk FactorsUnited States

Identifiers

PMID27403739
PMCPMC4942097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.